Bridger Management, Llc Buys Regeneron Pharmaceuticals Inc, UnitedHealth Group Inc, Incyte Corp, Sells Zimmer Biomet Holdings Inc, Zogenix Inc, Humana Inc

Author's Avatar
May 16, 2020
Article's Main Image
New York, NY, based Investment company Bridger Management, Llc (Current Portfolio) buys Regeneron Pharmaceuticals Inc, UnitedHealth Group Inc, Incyte Corp, MGM Resorts International, Hill-Rom Holdings Inc, sells Zimmer Biomet Holdings Inc, Zogenix Inc, Humana Inc, Heron Therapeutics Inc, LivaNova PLC during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Bridger Management, Llc. As of 2020Q1, Bridger Management, Llc owns 36 stocks with a total value of $864 million. These are the details of the buys and sells.

For the details of BRIDGER MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/bridger+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of BRIDGER MANAGEMENT, LLC
  1. GoDaddy Inc (GDDY) - 997,145 shares, 6.59% of the total portfolio. Shares reduced by 9.11%
  2. Centene Corp (CNC) - 896,873 shares, 6.17% of the total portfolio. Shares reduced by 27.06%
  3. Post Holdings Inc (POST) - 576,043 shares, 5.53% of the total portfolio.
  4. Natera Inc (NTRA) - 1,554,808 shares, 5.37% of the total portfolio. Shares added by 24.11%
  5. Regeneron Pharmaceuticals Inc (REGN) - 91,797 shares, 5.19% of the total portfolio. New Position
New Purchase: Regeneron Pharmaceuticals Inc (REGN)

Bridger Management, Llc initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $336.18 and $494.43, with an estimated average price of $411.31. The stock is now traded at around $576.72. The impact to a portfolio due to this purchase was 5.19%. The holding were 91,797 shares as of .

New Purchase: UnitedHealth Group Inc (UNH)

Bridger Management, Llc initiated holding in UnitedHealth Group Inc. The purchase prices were between $194.86 and $305.31, with an estimated average price of $276.19. The stock is now traded at around $290.96. The impact to a portfolio due to this purchase was 4.25%. The holding were 147,384 shares as of .

New Purchase: Incyte Corp (INCY)

Bridger Management, Llc initiated holding in Incyte Corp. The purchase prices were between $63.18 and $87.32, with an estimated average price of $75.84. The stock is now traded at around $96.12. The impact to a portfolio due to this purchase was 3.62%. The holding were 426,708 shares as of .

New Purchase: Hill-Rom Holdings Inc (HRC)

Bridger Management, Llc initiated holding in Hill-Rom Holdings Inc. The purchase prices were between $74.88 and $116.34, with an estimated average price of $104. The stock is now traded at around $99.84. The impact to a portfolio due to this purchase was 2.22%. The holding were 190,426 shares as of .

New Purchase: Ironwood Pharmaceuticals Inc (IRWD)

Bridger Management, Llc initiated holding in Ironwood Pharmaceuticals Inc. The purchase prices were between $8.58 and $14.01, with an estimated average price of $11.8. The stock is now traded at around $11.13. The impact to a portfolio due to this purchase was 1.8%. The holding were 1,544,590 shares as of .

New Purchase: Laboratory Corp of America Holdings (LH)

Bridger Management, Llc initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $104.32 and $195.28, with an estimated average price of $168.3. The stock is now traded at around $167.43. The impact to a portfolio due to this purchase was 1.63%. The holding were 111,157 shares as of .

Added: MGM Resorts International (MGM)

Bridger Management, Llc added to a holding in MGM Resorts International by 144.78%. The purchase prices were between $7.14 and $34.54, with an estimated average price of $26.07. The stock is now traded at around $13.85. The impact to a portfolio due to this purchase was 2.26%. The holding were 2,798,796 shares as of .

Added: Natera Inc (NTRA)

Bridger Management, Llc added to a holding in Natera Inc by 24.11%. The purchase prices were between $17.27 and $40.17, with an estimated average price of $33.52. The stock is now traded at around $45.23. The impact to a portfolio due to this purchase was 1.04%. The holding were 1,554,808 shares as of .

Sold Out: Zimmer Biomet Holdings Inc (ZBH)

Bridger Management, Llc sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $80.63 and $160.4, with an estimated average price of $135.85.

Sold Out: Zogenix Inc (ZGNX)

Bridger Management, Llc sold out a holding in Zogenix Inc. The sale prices were between $17.8 and $56.59, with an estimated average price of $36.87.

Sold Out: Humana Inc (HUM)

Bridger Management, Llc sold out a holding in Humana Inc. The sale prices were between $214.43 and $380.2, with an estimated average price of $338.77.

Sold Out: Heron Therapeutics Inc (HRTX)

Bridger Management, Llc sold out a holding in Heron Therapeutics Inc. The sale prices were between $10.23 and $24.53, with an estimated average price of $18.95.

Sold Out: LivaNova PLC (LIVN)

Bridger Management, Llc sold out a holding in LivaNova PLC. The sale prices were between $34.22 and $76.49, with an estimated average price of $65.13.

Sold Out: The Medicines Co (MDCO)

Bridger Management, Llc sold out a holding in The Medicines Co. The sale prices were between $84.9 and $84.96, with an estimated average price of $84.93.



Here is the complete portfolio of BRIDGER MANAGEMENT, LLC. Also check out:

1. BRIDGER MANAGEMENT, LLC's Undervalued Stocks
2. BRIDGER MANAGEMENT, LLC's Top Growth Companies, and
3. BRIDGER MANAGEMENT, LLC's High Yield stocks
4. Stocks that BRIDGER MANAGEMENT, LLC keeps buying